Wall Street Zen downgraded shares of Addus HomeCare (NASDAQ:ADUS - Free Report) from a buy rating to a hold rating in a research note released on Saturday.
ADUS has been the subject of several other research reports. Macquarie reaffirmed an "outperform" rating and issued a $133.00 price target on shares of Addus HomeCare in a research report on Tuesday, June 10th. Stephens reiterated an "overweight" rating and set a $142.00 target price on shares of Addus HomeCare in a research note on Wednesday, March 12th. Finally, JMP Securities restated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Friday. One research analyst has rated the stock with a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $142.57.
View Our Latest Stock Analysis on Addus HomeCare
Addus HomeCare Stock Up 0.9%
ADUS traded up $1.04 during midday trading on Friday, reaching $114.05. The company's stock had a trading volume of 214,521 shares, compared to its average volume of 170,748. Addus HomeCare has a 1 year low of $88.96 and a 1 year high of $136.72. The stock's 50-day moving average is $109.13 and its 200-day moving average is $111.78. The firm has a market capitalization of $2.10 billion, a price-to-earnings ratio of 25.74, a PEG ratio of 1.61 and a beta of 0.81. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.20.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating analysts' consensus estimates of $1.33 by $0.09. The company had revenue of $337.71 million during the quarter, compared to analyst estimates of $341.66 million. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The firm's revenue for the quarter was up 20.3% on a year-over-year basis. During the same quarter last year, the company earned $1.21 EPS. As a group, research analysts expect that Addus HomeCare will post 4.59 EPS for the current year.
Insider Activity
In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the transaction, the executive vice president now owns 7,796 shares of the company's stock, valued at approximately $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 4.60% of the company's stock.
Hedge Funds Weigh In On Addus HomeCare
A number of institutional investors have recently bought and sold shares of the stock. State of New Jersey Common Pension Fund D raised its stake in shares of Addus HomeCare by 17.1% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 17,464 shares of the company's stock worth $2,189,000 after buying an additional 2,553 shares during the period. New York State Common Retirement Fund increased its holdings in Addus HomeCare by 6.0% in the 4th quarter. New York State Common Retirement Fund now owns 14,098 shares of the company's stock worth $1,767,000 after acquiring an additional 800 shares in the last quarter. Alberta Investment Management Corp purchased a new stake in Addus HomeCare in the 4th quarter worth approximately $2,116,000. Handelsbanken Fonder AB raised its stake in Addus HomeCare by 17.2% during the 4th quarter. Handelsbanken Fonder AB now owns 4,083 shares of the company's stock worth $512,000 after acquiring an additional 600 shares during the period. Finally, Y Intercept Hong Kong Ltd purchased a new position in Addus HomeCare during the fourth quarter valued at approximately $258,000. 95.35% of the stock is owned by institutional investors.
About Addus HomeCare
(
Get Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Read More

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.